How to Calculate the Total Cost of Ownership for 3D-Printed Implants in Hospital Procurement

A procurement team can compare two implant quotations in a few minutes.

Working out which option will actually cost the hospital less is much harder.

One product may have a lower unit price but require more components, more backup inventory or more instrument trays. Another may cost more per implant but be used only in selected revision cases where the alternative reconstruction is already complex.

In patient-specific surgery, a simple “price per implant” comparison can become even less meaningful.

That is why orthopedic procurement needs a second number beyond purchase price:

Total Cost of Ownership, or TCO.

In practical terms, TCO asks:

What does it cost the hospital to make this reconstruction available, support the surgical workflow and manage it over the chosen evaluation period?

The answer is rarely found on a price list.

Purchase Price Still Matters—But It Is Only One Cost

Implant price matters immediately.

It affects the purchasing budget and is easy to compare.

But orthopedic implants sit inside a larger operating system.

Hospitals may also need to manage:

• instrument sets
• trial components
• inventory
• storage
• sterilization
• training
• clinical support
• urgent replenishment
• additional reconstruction components.

For complex reconstruction, the cost of the complete construct can matter more than the price of one implant.

That is where TCO becomes useful.

First Decide What You Are Comparing

Many cost analyses fail before the spreadsheet even begins.

A standard primary acetabular cup should not be compared with a patient-specific pelvic reconstruction as though they solve the same clinical problem.

Likewise, a 3D-printed revision component should not automatically be compared with the cheapest implant in the catalogue.

The correct question is:

What would we reasonably use for the same patient, the same defect and the same reconstruction objective if this product were unavailable?

Without the right comparator, even a mathematically accurate TCO can still lead to the wrong procurement conclusion.

Compare the Reconstruction, Not the SKU

Hospital price lists are organized by component.

Surgery is not.

A revision reconstruction may involve:

• an acetabular cup
• augments
• screws
• a cage
• a liner
• additional instruments.

Another strategy may use a different combination.

Procurement therefore needs to move from:

Component A vs. Component B

to:

Reconstruction Strategy A vs. Reconstruction Strategy B

A practical comparison may look like this:

Cost Element	Current Reconstruction	Proposed Reconstruction
Main implant	—	—
Augments / additional components	—	—
Screws / accessories	—	—
Instrument allocation	—	—
Inventory	—	—
Sterilization	—	—
Logistics	—	—
Planning / support	—	—
OR resource use	—	—
Total case cost	—	—

The cells should be populated with local hospital data wherever possible.

Not assumptions borrowed from another healthcare system.

Instruments Are Often Missing From the First Quotation

A quotation may list the implants clearly.

The instruments may be elsewhere—or not priced at all.

Yet they still have to exist.

Depending on the procedure, that may include:

• reamers
• broaches
• trials
• impactors
• cutting guides
• alignment tools
• extraction instruments.

For one hospital, a small number of sets may be enough.

For a hospital group, instrument economics can change quickly.

If several sites expect immediate access to the same system, procurement needs to understand how many sets are required, who owns them and who pays for additional sets.

A modest saving on implant price can easily be lost through an inefficient instrument model.

Inventory Has a Cost Even Without an Invoice

Orthopedic inventory is unusual.

One size may be implanted, but multiple sizes often need to be available.

Revision surgery makes this more demanding because surgeons may need backup constructs that are rarely used.

That stock occupies:

• capital
• storage
• staff time
• and may eventually face expiry or obsolescence.

Consignment may reduce the hospital's ownership of inventory.

It does not eliminate the work required to manage it.

Procurement should therefore distinguish between:

who owns the stock

and

who carries the operational burden of the stock.

Does 3D Printing Reduce Inventory?

Sometimes.

But not always.

A standardized 3D-printed acetabular component may still require a conventional range of sizes.

A patient-specific implant may require little finished-goods inventory, but instead introduce:

• imaging
• planning
• engineering
• scheduling
• case coordination.

The cost has not disappeared.

It has changed form.

That is a recurring lesson in TCO analysis: lower cost in one area may reappear as operational complexity somewhere else.

Revision Surgery Makes Logistics More Expensive

Primary arthroplasty is usually easier to forecast.

Revision is different.

Unexpected bone loss may require:

• additional stems
• augments
• screws
• cages
• liners
• alternative fixation.

A missing component can create much more than an express-freight charge.

It can lead to:

• rescheduling
• unused OR capacity
• additional staff coordination
• disruption to surgeon schedules.

Supply reliability therefore belongs in the economic discussion, even when it is difficult to assign one universal dollar value.

A supplier that repeatedly depends on emergency logistics can become expensive even when the catalogue price looks competitive.

Sterile Processing Should Not Be Invisible

Instrument trays need to be cleaned, sterilized, stored and turned over.

Those resources are not free.

A new implant system may change:

• tray count
• tray weight
• processing time
• storage requirements
• turnover demand.

The impact may be minor in one hospital and significant in another.

The useful question is not:

“Which system has the fewest instruments?”

It is:

“What sterile-processing burden does this system create at our case volume?”

OR Time Is Valuable—but Not Every Minute Becomes Cash

Economic models often multiply “minutes saved” by a theoretical cost per OR minute.

That can produce a very attractive number.

The hospital may never realize that saving.

Ten minutes saved only creates financial value if those minutes allow the organization to do something useful with the capacity, such as:

• perform another case
• reduce overtime
• reduce staffing requirements
• improve scheduling.

Otherwise, the benefit may be operational rather than cash-releasing.

This distinction matters because TCO models can become artificially favorable when every theoretical efficiency is treated as direct financial savings.

Training Has a Cost Even When the Course Is Free

Manufacturers may provide training at no charge.

That can be valuable.

But the hospital still uses:

• surgeon time
• nursing time
• clinical specialist time
• training facilities
• sometimes travel.

For one surgeon, the cost may be limited.

Across a large hospital network, it can become meaningful.

Implementation effort therefore belongs in the TCO model alongside product cost.

Patient-Specific Reconstruction Needs a Different Cost Logic

Patient-specific reconstruction should not simply use the same economic model as a standard implant.

The workflow may include:

Imaging → 3D Reconstruction → Clinical Review → Design → Manufacturing → Case-Specific Instruments → Delivery → Surgery

That process may create value in cases where standard reconstruction is difficult.

It also introduces additional resources and lead time.

The more useful question is not:

“Why is the custom implant more expensive?”

It is:

“What would the complete standard or modular reconstruction cost for this same case, and what compromises would it require?”

Standard and Patient-Specific Products Need Different Benchmarks

A standard 3D-printed component may be evaluated across hundreds of cases.

A patient-specific pelvic reconstruction might be evaluated for one patient.

One is primarily a product-line economics question.

The other is a case economics question.

Standard 3D-Printed Implant	Patient-Specific Reconstruction
Portfolio-level purchasing	Case-level approval
Repeated use	Individualized use
Inventory relevant	Design and lead time more relevant
Standard instruments	Case-specific tools may apply
Price benchmarking possible	Comparator must be case-specific
Volume affects economics	Anatomy and reconstruction drive economics

Combining the two into one average can obscure both.

Be Careful With “Future Revision Savings”

This is one of the easiest ways to make a new product look cheaper on paper.

Assume fewer revisions.

Add theoretical savings.

The model suddenly becomes attractive.

But if product-specific evidence does not support a lower revision rate, those savings remain assumptions.

A more credible method is:

Base case: assume no revision advantage.

Then add separate scenarios only when relevant evidence supports them.

This makes it clear how much of the result depends on uncertain long-term benefit.

Keep Measured, Estimated and Modelled Costs Separate

This distinction makes a TCO analysis much easier to trust.

Measured Costs

• implant price
• instrument cost
• freight
• sterilization
• inventory
• training expenditure.

Estimated Costs

• OR resource change
• staff time
• planning burden.

Modelled Costs

• future revisions
• readmissions
• long-term clinical savings.

The farther the analysis moves from directly observed costs, the more transparent the assumptions should become.

That prevents uncertainty from being presented as fact.

A Useful TCO Model Does Not Need to Be Complicated

For many hospitals, five questions are enough.

Acquisition

What are we buying?

Implementation

What do we need in order to use it?

Operation

What does each case consume?

Downstream

What evidence-based consequences occur after the procedure?

Alternative

What would we otherwise have used?

Then compare the complete pathways.

A practical summary is:

TCO = Everything the hospital reasonably spends to make the reconstruction possible and support it over the chosen evaluation period.

The categories may vary.

The logic should not.

Use More Than One Scenario

Future costs are rarely known with certainty.

Hospitals can therefore model three versions.

Conservative

No assumed savings in OR time, length of stay or revision.

Expected

Uses local data and the most defensible evidence.

Upside

Includes additional benefit if the technology performs better than baseline.

The goal is not to create three marketing numbers.

It is to show the procurement committee which assumptions actually drive the result.

If a product only appears economical in the upside scenario, leadership should know that before approving the investment.

Hospital Groups Should Look at Both Case Cost and Network Cost

A single hospital may ask:

What does this cost per case?

A healthcare group has another question:

What happens when we deploy this across several hospitals?

Group purchasing may create efficiencies through:

• centralized contracts
• pooled inventory
• standardized training
• fewer suppliers
• shared clinical pathways.

But network deployment may also increase:

• instrument requirements
• logistics
• implementation effort.

The network effect should therefore be measured, not assumed.

TCO, ROI and Cost-Effectiveness Are Different

These terms are often used interchangeably.

They should not be.

TCO

What does it cost us to own and use this solution?

ROI

Does the value created exceed the additional investment?

Cost-effectiveness

Are the additional clinical outcomes worth the additional cost?

A procurement committee may need all three.

For this discussion, the focus is TCO.

Where AK Medical Fits

For AK Medical, the strongest procurement argument is not:

“3D-printed implants are cheaper.”

That statement would be too broad and difficult to defend across products and markets.

A more credible position is:

The economic value of a 3D-printed, revision or patient-specific solution should be evaluated at the level of the complete reconstruction—not by implant price alone.

For a hospital assessing an AK Medical solution, the discussion can begin with the actual case or service line:

• What is the current reconstruction?
• What additional components does it require?
• What instruments are already available?
• What stock needs to be held?
• What new workflow would be introduced?
• What evidence supports any expected downstream benefit?

This changes the conversation from:

“How much is the implant?”

to:

“What does the complete treatment pathway cost us?”

Evaluating the TCO of an AK Medical Reconstruction?

Hospitals, healthcare groups and procurement teams comparing 3D-printed, revision or patient-specific orthopedic solutions can begin with a product-specific procurement review.

To make the first discussion more useful, you may provide:

• country or region
• hospital or healthcare group
• procedure or reconstruction being evaluated
• current implant or reconstruction strategy
• approximate annual case volume
• current instrument and inventory model
• areas where cost, workflow or supply is difficult.

A Simple Procurement Worksheet

Before introducing a new 3D-printed implant, procurement teams can use a one-page comparison:

Question	Current Pathway	Proposed Pathway
Complete implant construct	—	—
Number of components	—	—
Instruments required	—	—
Inventory required	—	—
Sterile processing	—	—
Freight / logistics	—	—
Training	—	—
Clinical support	—	—
OR resource use	—	—
Evidence-based downstream cost	—	—
Total	—	—

Add one line underneath:

Assumptions not yet supported by local data: __________________

That line may be more useful than another formula.

Request a Hospital Procurement & TCO Review

Comparing implant prices is only the beginning.

A meaningful procurement review considers the complete reconstruction pathway—including implants, components, instruments, inventory, sterilization, logistics, training, clinical support and other resources needed to make the solution available in practice.

Hospitals, healthcare groups and GPOs evaluating AK Medical solutions can begin with a product-specific procurement discussion.

Useful information may include:

• procedure or reconstruction being evaluated
• current implant or construct
• annual case volume
• instrument requirements
• inventory model
• sterilization and logistics arrangements
• revision case mix
• current supplier model.

AK Medical can then provide relevant product and regulatory information so your organization can compare the proposed solution with the clinically appropriate alternative using its own procurement framework and local cost data.

Contact AK Medical

For hospital procurement, 3D-printed implant evaluation, revision reconstruction, patient-specific reconstruction or Total Cost of Ownership discussions:

International Sales

Email: sales@ak-medical.net

Official WhatsApp: +86 150 0110 2275

To make the first discussion more relevant, include:

Country / Region + Hospital or Group + Clinical Procedure + Approximate Annual Case Volume + Current Reconstruction Strategy

Hospitals still in the research stage may also request:

• Product Catalogue
• Surgical Techniques
• instrument information
• market-specific regulatory information
• product availability
• technical documentation.

Frequently Asked Questions

What is Total Cost of Ownership for an orthopedic implant?

TCO is the total cost associated with making the implant or reconstruction available and usable, including acquisition, instruments, inventory, logistics, sterilization, training, support and other relevant resources.

Is implant price the same as TCO?

No. Implant price is only one component of total cost.

Are 3D-printed orthopedic implants always more expensive?

No general conclusion can be made. Cost depends on the product, reconstruction, market and clinically appropriate comparator.

Do 3D-printed implants reduce inventory?

Sometimes the inventory model changes. Standardized 3D-printed implants may still require multiple sizes, while patient-specific implants may reduce finished-goods inventory but increase planning and coordination requirements.

Should future revision savings be included?

Only when supported by relevant evidence or presented transparently as a modelling scenario.

How should hospitals compare revision implants?

Compare complete reconstruction strategies—including components, instruments and workflow requirements—not individual SKU prices.

Is TCO the same as ROI?

No. TCO measures the cost of owning and using a solution. ROI asks whether the value created exceeds the investment.

Is TCO the same as cost-effectiveness?

No. Cost-effectiveness compares cost with clinical outcomes.

Why use conservative and expected scenarios?

Because future utilization and outcomes are uncertain. Scenario analysis shows how dependent the result is on particular assumptions.

What is the most important question in a TCO comparison?

What is the clinically appropriate alternative for the same case?

Professional Notice

This article is intended for professional hospital procurement, GPO evaluation, supplier due diligence and health-economic discussion.

It does not constitute medical, legal, financial or patient-specific advice.

Total Cost of Ownership varies by institution, healthcare system, product, procedure, clinical pathway and procurement model. Hospitals should use local data and a clinically appropriate comparator.

Claims involving OR time, length of stay, complications, revision or other downstream effects should only be included when supported by relevant evidence or clearly identified as assumptions.

AK Medical products, indications, configurations, regulatory status, availability and commercial terms may differ between markets. Product-specific documentation should be reviewed before procurement or clinical implementation.